| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83085-008-10 | 83085-008 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline mesylate | TABLET | ORAL | 20221201 | N/A | ANDA | ANDA218163 | SKG Pharma Inc. | RASAGILINE MESYLATE | .5 mg/1 | 1000 TABLET in 1 BOTTLE (83085-008-10) |
| 83085-008-30 | 83085-008 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline mesylate | TABLET | ORAL | 20221201 | N/A | ANDA | ANDA218163 | SKG Pharma Inc. | RASAGILINE MESYLATE | .5 mg/1 | 30 TABLET in 1 BOTTLE (83085-008-30) |
| 83085-008-50 | 83085-008 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline mesylate | TABLET | ORAL | 20221201 | N/A | ANDA | ANDA218163 | SKG Pharma Inc. | RASAGILINE MESYLATE | .5 mg/1 | 500 TABLET in 1 BOTTLE (83085-008-50) |
| 83085-007-10 | 83085-007 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline mesylate | TABLET | ORAL | 20221201 | N/A | ANDA | ANDA218163 | SKG Pharma Inc. | RASAGILINE MESYLATE | 1 mg/1 | 1000 TABLET in 1 BOTTLE (83085-007-10) |
| 83085-007-30 | 83085-007 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline mesylate | TABLET | ORAL | 20221201 | N/A | ANDA | ANDA218163 | SKG Pharma Inc. | RASAGILINE MESYLATE | 1 mg/1 | 30 TABLET in 1 BOTTLE (83085-007-30) |
| 83085-007-50 | 83085-007 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline mesylate | TABLET | ORAL | 20221201 | N/A | ANDA | ANDA218163 | SKG Pharma Inc. | RASAGILINE MESYLATE | 1 mg/1 | 500 TABLET in 1 BOTTLE (83085-007-50) |